|
|
Other links at Articles > Rheumatology |
| 2. |
FDA Panel Recommends Approval of Belimumab in SLE
|
|
|
An FDA advisory panel voted in favor of approving belimumab in adult patients with active, autoantibody-positive systemic lupus erythematosus who are receiving standard therapy. Medscape Medical News
|
| 4. |
Peptide P140 a Promising Treatment for SLE
|
|
|
Immunotherapy with the novel investigational agent spliceosomal peptide P140 (IPP-201101; Lupuzor) safely improves the clinical and biological status of patients with systemic lupus erythematosus (SLE), according to results of an early phase II clinical trial. Reuters Health Information
|
|
|
